Concepedia

Kamala Kesavan

KK

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

2001

Affiliations

University of Colorado Denver(Current)

La Roche College

National Jewish Health

Purdue University West Lafayette

University of Colorado Health

Kamala Kesavan is an author at University of Colorado Denver specializing in cell biology, cell signaling, and life sciences.

Publications per year

2001–2023

11

Publications

11

Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

Yong S. Chang, Bradford Graves, Vincent Guerlavais et al. · Proceedings of the National Academy of Sciences · 2013 · 661 citations · Full text

, , +15

MEKK2 Associates with the Adapter Protein Lad/RIBP and Regulates the MEK5-BMK1/ERK5 Pathway

Weiyong Sun, Kamala Kesavan, Brian C. Schaefer et al. · Journal of Biological Chemistry · 2001 · 160 citations · Full text

, , +13

Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects

Kamala Kesavan, Judson Ratliff, Eric W. Johnson et al. · Journal of Biological Chemistry · 2009 · 135 citations · Full text

, , +12

Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development

Vincent Guerlavais, Tomi K. Sawyer, Luis A. Carvajal et al. · Journal of Medicinal Chemistry · 2023 · 125 citations · Full text

, , +14

Analysis of Notch1 Function by In Vitro T Cell Differentiation of <i>Pax5</i> Mutant Lymphoid Progenitors

Sonja Höflinger, Kamala Kesavan, Martin Fuxa et al. · The Journal of Immunology · 2004 · 104 citations · Full text

, , +17

1–5 of 11